Form 10-Q Asterias Biotherapeutics For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Asterias Biotherapeutics (AST) Tops Q2 EPS by 7c
August 15, 2016 4:59 PM EDTAsterias Biotherapeutics (NYSE: AST) reported Q2 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.53 million versus the consensus estimate of $1.14 million.
For earnings history and earnings-related data on Asterias Biotherapeutics (AST) click here.
... More